NTCP modeling of late effects for head and neck cancer: A systematic review

Sonja Stieb; Anna Lee; Lisanne V. Van Dijk; Steven Frank; Clifton David Fuller; Pierre Blanchard

doi:10.14338/20-00092

NTCP modeling of late effects for head and neck cancer: A systematic review

Sonja Stieb, Anna Lee, Lisanne V. Van Dijk, Steven Frank, Clifton David Fuller, Pierre Blanchard

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

12 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	95-107
Nombre de pages	13
journal	International Journal of Particle Therapy
Volume	8
Numéro de publication	1
Les DOIs	https://doi.org/10.14338/20-00092
état	Publié - 1 juin 2021

Accès au document

10.14338/20-00092

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{95b17e2a116e4780a5b442d1e8e3b74b,

title = "NTCP modeling of late effects for head and neck cancer: A systematic review",

author = "Sonja Stieb and Anna Lee and {Van Dijk}, {Lisanne V.} and Steven Frank and Fuller, {Clifton David} and Pierre Blanchard",

note = "Funding Information: Conflicts of Interest: Sonja Stieb, MD received funding from the Swiss Cancer League (BIL KLS-4300-08-2017). Anna Lee, MD, MPH received funding and salary support unrelated to this project from the National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Programs for Residents and Clinical Fellows Grant (R25EB025787-01). Steven J. Frank, MD is an Associate Editor of the International Journal of Particle Therapy. Dr. Frank is a paid consultant/advisory board member for Varian and advisory board member for Hitachi and Breakthrough Chronic Care. He is founder and director of and has received grants and personal fees from C4 Imaging. He reports grants from Eli Lilly, Elekta, grants and honoraria from Hitachi and personal fees from Boston Scientific and the National Comprehensive Cancer Center (NCCN). Clifton David Fuller, MD, PhD has received direct industry grant support, speaking honoraria and travel funding from Elekta AB. Dr. Fuller received funding from the National Institute for Dental and Craniofacial Research Award (1R01DE025248-01/R56DE025248) and Academic-Industrial Partnership Award (R01DE028290), the NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148) outside the scope of this project. The authors have no relevant conflicts of interest to disclose. Funding: Clifton David Fuller, MD, PhD received funding in support of this project from the Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF1557679), the National Institutes of Health (NIH) Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825), the NIH/ NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672), the NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50CA097007), and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25EB025787). Ethical approval: This review did not involve human subjects/participants and was exempt from institutional review board approval.",

year = "2021",

month = jun,

day = "1",

doi = "10.14338/20-00092",

language = "English",

volume = "8",

pages = "95--107",

journal = "International Journal of Particle Therapy",

issn = "2331-5180",

number = "1",

}

TY - JOUR

T1 - NTCP modeling of late effects for head and neck cancer

T2 - A systematic review

AU - Stieb, Sonja

AU - Lee, Anna

AU - Van Dijk, Lisanne V.

AU - Frank, Steven

AU - Fuller, Clifton David

AU - Blanchard, Pierre

N1 - Funding Information: Conflicts of Interest: Sonja Stieb, MD received funding from the Swiss Cancer League (BIL KLS-4300-08-2017). Anna Lee, MD, MPH received funding and salary support unrelated to this project from the National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Programs for Residents and Clinical Fellows Grant (R25EB025787-01). Steven J. Frank, MD is an Associate Editor of the International Journal of Particle Therapy. Dr. Frank is a paid consultant/advisory board member for Varian and advisory board member for Hitachi and Breakthrough Chronic Care. He is founder and director of and has received grants and personal fees from C4 Imaging. He reports grants from Eli Lilly, Elekta, grants and honoraria from Hitachi and personal fees from Boston Scientific and the National Comprehensive Cancer Center (NCCN). Clifton David Fuller, MD, PhD has received direct industry grant support, speaking honoraria and travel funding from Elekta AB. Dr. Fuller received funding from the National Institute for Dental and Craniofacial Research Award (1R01DE025248-01/R56DE025248) and Academic-Industrial Partnership Award (R01DE028290), the NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148) outside the scope of this project. The authors have no relevant conflicts of interest to disclose. Funding: Clifton David Fuller, MD, PhD received funding in support of this project from the Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF1557679), the National Institutes of Health (NIH) Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825), the NIH/ NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672), the NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50CA097007), and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25EB025787). Ethical approval: This review did not involve human subjects/participants and was exempt from institutional review board approval.

PY - 2021/6/1

Y1 - 2021/6/1

UR - http://www.scopus.com/inward/record.url?scp=85115758917&partnerID=8YFLogxK

U2 - 10.14338/20-00092

DO - 10.14338/20-00092

M3 - Review article

AN - SCOPUS:85115758917

SN - 2331-5180

VL - 8

SP - 95

EP - 107

JO - International Journal of Particle Therapy

JF - International Journal of Particle Therapy

IS - 1

ER -